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Synthesis of the ncurotransmittcr acetylcholine in cholinegic nerve terminals is regulated by a sodiumdriven high-affinity choline uptake sy~tum 
in the plasma membrane. We have isolated cDNAs from rat spinal cord and brainstem which encode a choline transporter (CHOTI). The prodictcd 
protein shares considerable amino acid identity and several structural features including twelve putative transmcmbranc regions with other 
ncurotransmitter transporters. Expression of in vitro transcribed CHOTI RNA in Xenopus oocylcs Seencrated Na’depndcnt choline uptake. which 
was not seen in control oocytes. Amplification by polymcrase chain reaction (PCR) revealed significant amounts of CHOTl mRNA in brain, 
cerebellum, spinal cord and, to a lesser extent, heart, but only very low expression i  lung, kidney and muscle. 
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1. INTRODUCTION 
Acetylcholine (ACh) was the first neurotransmitter to
be identified in the nervous system [l]. After its release 
from presynaptic terminals, ACh binds to postsynaptic 
nicotinic and muscarinic ACh receptors, which activate 
distinct signal transduction mechanisms. Neurotrans- 
mission is terminated by dissociation of ACh from the 
receptor fol!owed by its rapid enzymatic hydrolysis and 
reuptake of choline from the synaptic left into the pre- 
synaptic terminai (reviewed in [2-4]), Different investi- 
gators have shown that this reuptake process provides 
the major source of choline for the de novo synthesis of 
ACh [3,4]. Choline uptake therefore constitutes a rate- 
limiting step in .jCh synthesis, and its modulation has 
been implicated in the control of synaptic efficacy [5-73. 
[3MjCholine-uptake studies with synaptosomes [8-lo] 
and denervation experiments [l l-l 31 indicate the pres- 
ence of a No+-dependent high-aflinity choline transport 
system at cholinergic nerve endings. Also, specific bind- 
ing sites for the competitive inhibitor of choline uptake, 
hemicholinium3 [S, 143, have been demonstrated in 
brain tissue [15,16], and covalent attachment of this 
inhibitor as well as antibody labeling have been used to 
identify the insect neuronal choline transporter as a 
polypeptide of 80 kDa [ 17,151. Migh affinity for choline 
and the requirement for Na’ discriminate the neural 
choline uptake from an ubiquitous low-affinity choline 
transporter system, which provides the precursor for 
phospholipid synthesis in most types of cells [3,4,9]. 
Recently, purification of a GABA transporter protein 
from rat brain [I91 and molecular cloning of different 
cDNAs encoding Na’-dependent mammalian neuro- 
transmitter transporters have unraveled characteristic 
structural features of this family of membrane proteins 
[20]. The GABA (GATl) [21,22], noradrenaline (NETI) 
[23], serotonin (SERTI) [24-261 and dopamine (DATl) 
[27-301 transporters all share a common predicted 
transmembrane topology, with 12 putative membrane 
spanning segments, and significant amino acid identity 
(30-65%) along most of their sequence. We have ex- 
ploited this conservation to search for cDNAs encoding 
novel neurotransmitter transporters by using the 
polymerase chain reaction (PCR) with degenerate ol- 
igonucleotides deduced from different regions of the 
GATl sequence [26]. Here we report that functional 
expression in Xetnopus oocytes revealed one of our 
cDNA clones to encode a Na+-dependent high-affinity 
choline transporter (CMOTl). 
2. MATERIALS AND METI-IODS 
2.1. PCA anlplificnrion 
PCR was performed on olip(dT)-primed cDNA isolated from tat 
spinal cord as described 1261 using the folrowing degenerate digonu- 
cleotides complementary tothe rat GATI cDNA [Xl]: T’GGCTT(C/ 
T)GT(C/Ci)AT(Crr)Tf(C/r)TCCATC-3’ (sense, corresponding to 
nucleoiidc positions 1003-1023~; and S’-GAA(UG)CG(GIA)TT(G/ 
C)AC(A/C)CC(A/G)TA(A/G)AACCA-3’ (antisense. complementary 
to nucleotide positions 1417’1440). The -44O~bpampliRcation product 
was cleaved by the restriction enzyme Aval, and residual undigested 
DNA was subcloned into pBluescript SK- and subjected to didcoxy 
sequencing [3 I] using synthetic pritncris. 
Correspondme address: H. Betz, Max-Planck-Institut fttr Hirn- 
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2.2. [solarion and seqvencc analysh o~cDNA clones 
A rat spinal cord cDNA library constructed inmPII (7.5~10’ pfu) 
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was screened with the ‘zP-labelled A~440 fragment under the Wow- 
ing hybridization conditions: _“0% (v/v) formamide. 750 mM NaCI, 75 
mMTris-I-ICI, pH 7.5.12.5 mM EDTA, 0.1% (w/v) SDS, SxDcnhard’s 
solution and lOO,@ml salmon sperm DNA at SO’C for I4 h. Filters 
were washed in 0.2 x SSC, 0.1% (w/v) SDS at 65°C for 40 min, Inserts 
were excised from hybridization-positive phages as described in the 
Stratagene manual. Since no full-length c!ones were derived From this 
procedure, a rdndomly-primed &I I-I cDNA library preparcd from rat 
brainstem (Clontech) was in addition scrc-ncd with the “P-labelled 
Ava440 fragment. Phagc DNA was prepared, and inserts were sub- 
cloned into pbluescript KS following standard procedures [32]. 
2.3. E.xprrssiott oj’ CHOTI in oocyres 
CHOTI RNA was synthxized from the A15 cDNA subloned in 
pBIuescript KS by in vitro transcription using a commercinl kit (Strat- 
agene). Defolliculated oocytes of Xenopus fuevis were prepared and 
injected with 50 nl of the CHOT-I cRNA (I ,~g&l) as described [33], 
After IWO days, individual oocytes were incubated in 200 ~1 of trans- 
pan buffer 1 (TBI: 100 mM NaCI, 2 mM KCI, I mM CaClz, I mM 
MgCIj, and 10 mM HEPES, PI-I 7,5) containing 0.25-1.0 PM 
[“H]cholinc (specific activity 85 Wmmol: NEN, Dreieich, Germany). 
After I h at room temperature, the oocytes were washed 3 times in 
TBI, transferred into scintillation vials, solubilized by the addition or 
1OOyl of 10% (w/v) SDS, and radioactivity was determined by liquid 
scintillation counting. For evaluating spxific CHOTI mediated 
choline transport, values were corrected For tracer accumulation ob- 
tained with non-injected oocytes. All values represent he mean 
2S.E.M. of 4-6 individual oocytes. 
Poly(A)+RNA was isolated from various rat tissues and reversc- 
transcribed into single-stranded cDNA using a commercial kit 
(Boehringcr). PCR amplification of these cDNAs was performed as 
described [26] using two pairs of oligonucleotide primers correspond- 
ingto nucleotide positions651-674 (sense), l739-17G3 (antisense), and 
1227-1251 (antisense), of the CHOTf cDNA. After 25 cycles, 3yl of 
each reaction were separated on 1% agarosc gels, blotted onto Nylon 
mcmbmnes. and specific amplification products were visualized by 
hybridization with radiolabeled CHOTl cDNA probes. Parallel am- 
plification or actin sequences was used to check the integrity and 
relative amounts of the different cDNA samples (see [26]). 
3. RESULTS 
3.1. Str.uctrrre of CHUTl cDNA ard proteitt 
In an attempt o clone putative transporter cDNAa 
from rat spinal cord, degenerate sense and antisense 
oligonucleotides covering selected sequences of the rat 
GATl cDNA [21] were designed to encompass aregion 
which contains a unique AvaI site at nucleotide position 
1105 Using these oligonucleotides for PCR amplifica- 
tion of spinal cord cDNA, a product of -440 bp was 
obtained, which was subjected to AvaI digestion. In 
addition to the expected fragments of 335 bp and 102 
bp corresponding to CiATl , uncleaved amplification 
product remained. Subcloning and sequence analysis of 
this DNA revealed a novel nucleotide sequence har- 
bouring an open reading frame homologous to GATl , 
We therefore used this fragment, termed Ava440, to 
screen a ZAPII rat spinal cord cDNA library under 
high stringency conditions. This resulted in the isolation 
of a partial 2691 bp clone, termed A40, which covered 
a large portion of the novel open reading frame and the 
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3’-untranslated sequence including a potential poiyad- 
enylation signal and a stretch of several A residues. To 
obtain the S-coding region, a AgtlO cDNA library pre- 
pared from rat brainstem was screened with a -800 bp 
5’ probe derived from the original A40 clone. This iden- 
tliied dn overlapping cDNA (AlS) of 2741 bp with an 
open reading frame of 1905 bp (Fig. 1). The initiation 
codon was assigned to an ATG at positions 637-639 on 
the basis of the Kozak initiation consensus equence 
[34]. The open reading frame encodes a mature protein 
of 635 amino acids with a calculated molecular weight 
of 70,631 Da and a theoretical isoelectric point of 6.38. 
The protein deduced from the Al5 cDNA shares 
many structural features with known neurotransmitter 
transporter sequences. Twelve hydrophobic segments of 
18-25 amino acid residues qualify as putative trans- 
membrane domains (Fig. 2), and the lack of a N-termi- 
nal hydrophobic signal sequence suggests a transmem- 
brone topology identical to that proposed for other 
transporters, with both N and C termini being located 
cytoplasmically. Two consensus ites for N-glycosyla- 
tion are present in a large presumptive xtracellular 
region between transmembrane segments III and IV 
(Fig. 1); this region diverges between the different rans- 
porters, but invariably contains N-glycosylation sites 
[20]. A furtPer potential site for N-glycosylation is 
found in the most C-terminal extracellular loop between 
transmembrane domains XI and XII. Consensus ites 
for phosphorylation by protein kinase C and tyrosine 
kinase are located in the cytoplasmic N-terminal region 
and the short loop connecting transmembrane Aegments 
IV and V (Fig. 1). 
Sequence comparison with GATl, NETl, DATl and 
SERTl (Fig. 2) revealed a high degree of conservation; 
corresponding amino acid identities are 49%, 42%, 41% 
and 37%, respectively. With isofunctional replacements 
being in addition considered, homology values increase 
to 64% for GATI, 55% for NETl, 56% for DATl and 
53% for SERTl. The highest sequence identity (51%; 
homology 65%), however, is found with the recently 
cloned betaine transporter, BGTl, from kidney, which 
transports also GABA and represents another member 
of the Na’-dependent ransporter superfamily [35]. A 
dendrogram derived from the sequence alignment (Fig. 
2) places CHOTl into a subfamily including GATl and 
BGTl, whereas the catecholamine transporters form a 
distinct branch that is closely related to the SERTl 
protein. Most conserved residues and many isofunc- 
tional replacements are positioned within or adjacent o 
putative transmembrane s gments. No conservation is 
seen in the highly charged N- and C-terminal tails. 
3.2. Funcrioncrl exprasiorz in Xenopus oocytes 
In vitro transcribed Al5 RNA was injected into Xetz- 
opus oocytes to test its putative neurotransmitter trans- 
porter function, After incubation with f3H]choline, 
[3H]glycine or [‘HIglutamate, significant accumulation 
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Fig. I. Nucleotide and deduced amino acid sc+cnces of the rat 
CNOTl cDNA. A polyadcnylation signal in the 3’.untranslated re- 
gion of the nwleotide zquence is underlined. potential extracellular 
N-linked glycosylation sites are circled, and putative intracellular con- 
sensus equences for phosphorylation by protein kinase C and tyro- 
sine kinase are boxed. Numbering of nuclcotides and amino acids is 
indicated on the left side of the figure, Clone AI5 corresponds to 
nuc!cotidcs l-2741, and clone A40 to nucleotidcs 1281-3972. of the 
DNA sequence, 
of radioactivity exceeding that of non-injected controi 
oocytes was only seen with [3’H]choliile (Fig. 3A). At 1 
,uM [3H]clioline, this uptake was about S-10 times 
higher as compared to control oocytes. Moreover, no 
uptake was seen when Na’ was exchanged with Li’, 
indicating that transpcr: was Na+-dependent. Competi- 
tion studies with unlabelled substrate (Fig. 3B) revealed 
a maximal velocity (VmJ of 24.6 25.6 pmol/h of choline 
uptake per oocyte and a K,,, of 9.6 P3.9 ,uM (means of 
three independent experiments). The latter value is sim- 
ilar to those reported for the high-affinity choline up- 
take system present in rat brain synaptosomes [36]. Sur- 
prisingly, hemicholinium-3 had no significant effect on 
[3H]choline uptake up to concentrations of 10V5 M (not 
shown). Control experiments howed that [3H]choline 
uptake into non-injected oocytes differed from that seen 
upon cRNA expression in that (i) this uptake was not 
saturable up to 50 ,uM (Fig. 3B), and (ii) it showed no 
significant reduction upon substituting Na’ by Li’ (not 
shown). We hence conclude that the A15 cDNA en- 
codes a Na’-dependent high-affinity choline transporter 
protein, termed CHOTl. 
3.3. Tissue Distribution of CHOTI trunscripts 
Attempts to reveal CHOTl transcripts in rat brain 
and spinal cord by Northern analysis were unsuccessful; 
presumably expression of the corresponding gene is 
low. PCR was therefore used to amplify CHOTl se- 
quences from poly(A)‘RNA preparations i olated from 
different rat tissues after reverse transcription into 
cDNA. As demonstrated in Fig. 4A, a -1.1 kb PCR 
amplification produ.ct specific for CHOTl was readily 
detected in developing (postnatal days 1 and l(1) and 
adult spinal cord as well as in adult brain and cerebel- 
lum, but not in skeletal muscle, kidney, lung and heart. 
Using a second set of CHOTl-specific primers encom- 
passing a shorter (600 bp) region of the RNA, signiti- 
cant amounts of CHOTI amplification product were 
also revealed in heart (Fig. 4B). This result is unlikely 
to result from contamination by genomic DNA, but 
most likely reflects the presence of cholinergic cells in 
this organ. Indeed, autonomous innervation by cholin- 
ergic neurons is crucially implicated in the control of 
heart beat. Using a higher number of amplification cy- 
cles and/or longer autoradiographic exposure times, 
very low amounts of amplification product were also 
33 
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Fig. 2. Alignment ofNa’-dependent transporter proteins. Sequcnccs arc taken from the following references: BGTI, [35]; GATI, [21]; NETI, j23]; 
DATI. 1281; and SERTI, [26]. Amino acids identical in all transporters arc marked by asterisks. and isofunctional residues hared by at I%st four 
proteins by a dot. Putative transmembrane r gions arc indicated by bars. Gaps ware introduced to optimize identical sequence positions. A 
dendrogram at the C-terminal end of the scquenccs symbolizes the homology relationships between the individual transporters. 
seen in muscle, lung and kidney (data not shown). This 
may be due to the presence of intramura! parasympa- 
thetic ganglia. Control amplification with actin mRNA 
specific primers confumed the integrity of the RNA 
preparations used for reverse transcription (Fig. 4C). In 
conclusion, these PCR data are consistent with a local- 
ization of CHOTl transcripts in organs known to con- 
tain cholincrgic neurons. 
4. DISCUSSION 
Different lines of evidence indicate that the CI-IQTI 
cDNA described in this paper encodes a high-affinity 
choline transporter, which is highly expressed in the 
nervous system. First, the polypeptide sequence de- 
duced from the single continuous open reading frame 
displays considerable homology to previously cloned 
34 
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Choline bMJ 
Fig. 3. Expression of CHOTI in Xettopus oocytes. Xe~rqx~~ oocytes 
were injected with synthetic Al5 RNA, and [‘H]cholinc uptake was 
determined after 2 days as described in section 2. A. Uptake of 
[‘wglycinc, [3H]81utamatc nd [‘HIcholine in control (open bars) and 
injected (hatched bars) oocytes. B. Concentration dcpendcnce of 
[‘H]choline uptake. Saturation characteristics were determined by the 
addition of different concentrations of unlabelled c!loline, nnd lrans- 
port kinetic values calculalcd using the Eadie-Hofstee transformation 
[38]. Non-specifc uptake was determined using non-injected oocytes 
(0); these values were subtracted from those obtained with RNA- 
injected cells (0) to yield CHOTI-specilic uptake (0) data. (m), 
CHOTI-specific uptnke in buffer, where Na’ was substituted by Li’. 
K, and V_, values obtained in this particular experiment were 5.7yM 
and 20.7 pmoVh per oocytc. 
neurotransmitter t ansporters, e.g. the GATl, NETl, 
DATl and SERTl proteins, as well as the betaine trans- 
porter BGTI. In particular, the BGTl and GATl pro- 
teins show high sequence identities, suggesting that 
CHOTl may belong to an amino acid-related trans- 
porter subfamily. Also, the transmembrane topology 
suggested by hydropathy analysis [37] closely resembles 
that assumed for the other transporter proteins [20]. 
CHOTl thus clearly is a member of this integral mem- 
branc protein family. Second, heterologous expression 
of in vitro transcribed CHOTl mRNA in Xenopus 
oocytes generated Na”-dependent high-affinity 
[3H]choline uptake. Unexpectedly, this uptake was in- 
123456789 
Fig. 4. Distribution of CMOTI transcripts. F’CR arnpliftcation with 
CHOTl-speci8c oligonucleotide primer combinations (A, fragment of 
I 112 bp; B, fragment of698 bp) was performed in parallel using equal 
amounts of cDNA synthesized from poly(A)‘RNA isolated from dif- 
ferent rat tissues as detailed in section 2. Control amplifications were 
performed with a B actinqecitlc set of primer oligonuclcotidea (C). 
The following poly(A)‘RNA preparations were used: lane 1, spinal 
cord, postnatal day 1; lane 2, spinal cord, postnatal day 16; lane 3. 
spinal cord; lane 4, skeletal muscle; lane S, kidney; lane 6, heart; lane 
7, lung; lane 8, total brain; and lane 9. cerebellum. Lanes 3-9. tissue 
from adult (6-8 wcek.old) rats. 
sensitive to the classical choline transport blocker hem- 
icholinium-3 [8,14]; this may indicate that different 
choline transporter subtypes of distinct pharmacology 
may exist. Finally, PCR amplification of CHOTI tran- 
scripts revealed expression of the corresponding ene in 
brain, spinal cord, cerebellum and, to a lesser extent, 
heart. This distribution of CHOTl mRNA is consistent 
with the presence of cholinergic nerve cells in these tis- 
sues. 
Different sequence features of CHOTl and the other 
neurotransmitter t ansporter proteins enforce specula- 
tions about possible functional domains of these mem- 
brane proteins. Calculation of hydropathy values for 
the individual transmembrane s gments [371 and analy- 
sis of their sequence conservation between the different 
transporters uggest that some regions may be particu- 
larly important in substrate binding and/or transport 
function. First, the putative transmembrane segment I 
shows a very high degree of conservation (Fig. 2), but 
only a low content of hydrophobic residues. This seg- 
ment thus may be implicated in ion translocation and 
probably is centrally positioned in the assembled trans- 
porter. Segment IX in contrast is not well conserved and 
may have a spacific function in substrate binding, Sim- 
ilarly, the large extracellular loop connecting segments 
III and IV is highly divergent, and thus may also partic- 
ipate in substrate recognition and/or translocation. Re- 
gions involved in Na’ translocation have not been iden- 
tified; however, a glutamate residue (Glu-490 in 
CHOTl) is absolutely conserved in transmembrane s g- 
ment X. This side chain thus might constitute an intra- 
membrane binding site for Na+. Alternatively, it may 
stabilize transporter conformation by pairing with other 
intramembrane charged residues* e.g. a conserved 
arginine in segment I. Analysis of chimeric transporter 
constructs and site-directed mutagenesis experiments 
3s 
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should help to elucidate the precise role of these putative 
substrate and ion binding regions. 
Ackno~l:le~~ernenrs:We thank A. Nichuis for expert technical assis- 
tance, Dr. H. Breer. B. Matzenbach and A. Ultsch for many helpful 
suggestions, Dr. Y. Maulet for providing the spinal cord cDNA li- 
brary, Drs. D. Langosch and M. Duggan for critical reading or the 
manuscript, and S. Wartha for help with its preparation. This work 
was supported by Deutsche Fonchungsgemeinschaft (Leibniz Pro- 
gramm) and Fonds der Chemischen Industric. 
REFERENCES 
[I] Loewi, 0. (1921) Plltlgcr’s Arch. 189.239-242. 
[2] Kuhar, M.J. and Murrin, L.C. (1978) J. Neurochem. 30, 15-21. 
[3] Jope, R.S. (1979) Brain Res. Rev. I, 3 13-344. 
[4] Tucck, S. (1985) J. Neurochcm. 44, 1 l-24. 
[5] Atwch, S., Simon, J.R. and Kuhar, M.J. (1975) Life Sci. 17,1535- 
1544. 
[G] Murrin, L.C., DeHaven, R.N. and Kuhar, M.J. (1977) J. Neuro- 
chcm. 29, 681687. 
[7j Marchbanks, R.M. and Wonnacott, S. (1979) Prog. Brain Rcs. 
49, 77-88. 
[8] Diamond, I. and Kennedy, E.P. (1969) J. Biol. Chem. 244, 3258- 
3263. 
[9] Yamamura, H.J. nnd Snyder, S,H. (1972) Science 178,626-G28. 
[IO] Yamamura. H.J. and Snyder, S.H. (1973) J. Ncurochem. 21, 
1355-1374. 
[I I] Kuhar, M.J., Dehaven, R.N., Yamamura, H.I., Rommelspacher. 
H. and Simon, J.R. (1975) Brain Rcs. 97, 265-275. 
[12] Nadler, J.V., Shelton, D.L. and Colman, C.W. (1979) Brain Res. 
164.207-216. 
[13] Metcalf, R.H., Boegman, R.J., Quirion R., Riopelle. R.J. and 
Ludwin, S.K. (1987) J. Neurochcm. 49, 639-644. 
[14] Guycnct, P., Le Fresnu, P,, Rossicr, J., Bcaujouan, J.C. and 
Glowinski, J. (1973) Mol. Pharmacol. 9, 630-639. 
[IS] Rainbow, T.C.. Parsons, B. and Wieczorek, CM. (1954) Eur. J. 
Pharmacol. 102, 19S-19G. 
1161 Sandberg, K. and Coylc, J.T. (198s) Brain Rcs. 348, 321-330, 
[I71 Knipper, M.. Krieger. J. and Brcer, H. (1989) Neurochem. Int. 
14, 21 l-215. 
[18] Knipper, M., Strotmann, J., Mndler, U., Kahlc, C. and Breer, H. 
(1989; Ncurochem, Int. 14, 217-222. 
I!91 
PO1 
1211 
[x!] 
1231 
[241 
[251 
[261 
[27l 
[ZS] 
~291 
[301 
[3Il 
1321 
[331 
[341 
Radian, R.. Bcndahan, A. and Kanner, B.I. (1986) J. Biol. Chem. 
2Gl, lS437-15441. 
Amara, S.G. and Pacholczyk. T. (1991) Curr. Opin. Neurobiol. 
I, 8490. 
Guaslella. J.. Nelson, N., Nelson, H., Czyzyk, L., Keynan, S., 
Miedel, M.C., Davidson, N., Lester, H.A. and Kanner, B.I. 
(1990) Science 249, 1303-1306. 
Nelson, H.. Mandiyan, S. and Nelson, N. (1990) FEDS Lctt. 269, 
181-184. 
Pacholczyk, T., BlakclX, R.D. and Amara, S.G. (1991) Nature 
350, 350-354, 
Hoffman, B.J., Mezey, E. and Brownstein, M.J. (1991) Science 
254, 579-580. 
Blakely, R.D., Bersou, H.E., Fremeau Jr, R.T., Caron, M.G., 
Peek, M.M. Prince. H.K. and Bradley, CC. (1991) Nature 354, 
66-70. 
Mayser, W., Belz, H. and Schloss, 1’. (1991) FEBS Lett. 295, 
203-206. 
Shimada, S., Kitayama, S., Lin, C-L., Patel, A., Nanthakumar, 
E., Gregor, P., Kuhnr, M. and Uhl, G. (1991) Science 254.576- 
578. 
Kilty, J.E., Lorang, D. and Amara, S.G. (1991) Science 254, 
578-579. 
Giros. B., El Mcstikawy, S., Mertrznd, L. and Caron, M.G. (1991) 
FEBS Lea. 295, 149-154. 
Usdin, T.B., Mezey, E., Chen, C., Brownstein, M.J. and 
Hoflinann, BJ. (1991) Proc. Natl. Acad. Sci. USA 88, 1116% 
11171. 
Sanger. F., Nicklcn, S. and Coulson, A.R. (1977) Proc. Natl. 
Acad. Sci. USA 14, 5463-5467. 
Sambrook, J., Fritsch, E.F. and Maniatis, T. (1989) Cold Spring 
Harbour Laboratory Press, Cold Spring Harbour, NY. 
Schmiden, V., Grenningloh, G., Schofield, P.R. and Betz, H. 
(1989) EMBO J. 8,695-700. 
Cavener, D.R. and Ray, SC. (199l)NucleicAcidsRes. 19.3185- 
3192. 
[3Sl Yamauchi, A,, Uchida, S.. Kwon, H.M., Preston, AS., Brooks- 
Robey, R., Garcia-Perez, A., Burg, M.B. and Handler, J.S. (1992) 
J. Biol. Chem. 267, 649-652. 
1361 Haga, T. and Noda, H. (1973) Biochim. Biophys. Acta 291, 
SG4-575. 
[37] Kytc, J. and Doolittle, R.F.J. (1982) J. Mol. Biol. 157, 105-132. 
[38] Connors. K.A. (1987) Binding Constants, Wiley, New York, NY. 
c 
36 
